Crescina Development has been a time-tested dermato-cosmetic treatment for topical application focused on addressing hair thinning, activating the natural growth of hair and not another anti-hair loss product aimed at slowing down or preventing the detachment of existing hairs on the scalp. Crescina Transdermic HFSC Development is designed to prevent and address thinning caused by normal (non-pathological) factors and for cases where the quantity and quality of hair gradually decrease due to reduced activity of hair follicles.
The Crescina Transdermic HFSC Man 200 treatment is a specially designed male formula for the initial stages of thinning and is available in a pack containing 20 vials (one month's treatment). The vials contain 3.5 ml of formulation.
The patented formula, thanks to Labo's Transdermal Technology, allows active molecules to penetrate the hair system not only through the hair follicles but also transdermally, i.e., through the layers of the scalp (epidermis and dermis). Thanks to their low molecular weight and the presence of 3 absorption enhancers, penetration and the delivery of functional active ingredients are facilitated. The treatment achieves comprehensive action on all hair structures and its composition supports the natural growth of hair in healthy and semi-dormant follicles.
48 
